title: Evaluation of the biological activity of novel monocationic fluoroaryl-2,2'-bichalcophenes and their analogues.
abstract: A series of bichalcophene fluorobenzamidines 5a-e was synthesized from the corresponding mononitriles 4a-e via a direct reaction with lithium bis(trimethylsilyl)amide LiN(TMS)2 followed by de-protection with ethanolic HCl (gas). Bichalcophene fluorobenzonitriles 4a-e were prepared adopting a Stille coupling reaction between the bromo compounds 3a-c and 2-(tri-n-butylstannyl)furan or analogues. As an approach to drug discovery, the structure-antimutagenicity relationship of novel fluoroarylbichalcophenes was examined using the Ames Salmonella/microsomal assay. At nontoxic concentrations (10 and 20 μM), all derivatives alone or in combination with sodium azide (NaN3; 2 μg/plate) or benzo[a]pyrene (B[a]P; 20 μM) in the presence of S9 mix were not mutagenic. The fluoroaryl derivatives significantly reduced the NaN3-induced and B[a]P-induced mutagenicity under pre-exposure and co-exposure conditions. The recorded antimutagenic activity of fluoroaryl derivatives varied depending on the kind of mutagen and the exposure regimen. Monocationic fluoroarylbichalcophenes were superior to the corresponding mononitriles in reducing B[a]P-induced mutagenicity. Nevertheless, mononitriles were more active against NaN3, especially at low concentrations and under pre-exposure treatments. The antimutagenic activity was congruent with a high antioxidant activity that could promote the DNA repair system. The fluorine substitution changed the antimutagenic signature of bichalcophenes. Some of these compounds could be selected for further anticancer studies.
authors.affiliation: King Faisal University, College of Science, Departments of Chemistry and Biological Sciences, Hofuf, Saudi Arabia ; Al-Azhr University, Faculty of Science, Department of Botany and Microbiology, Cairo, Egypt.
authors.forename: Warda A
authors.initials: WA
authors.lastname: Hussin
authors.affiliation: King Faisal University, College of Science, Departments of Chemistry and Biological Sciences, Hofuf, Saudi Arabia ; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, Egypt.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Ismail
authors.affiliation: King Faisal University, College of Science, Departments of Chemistry and Biological Sciences, Hofuf, Saudi Arabia.
authors.forename: Abdullah M
authors.initials: AM
authors.lastname: Alzahrani
authors.affiliation: King Faisal University, College of Science, Departments of Chemistry and Biological Sciences, Hofuf, Saudi Arabia ; University of Ain Shams, Faculty of Science, Department of Zoology, Abbassia, Cairo, Egypt.
authors.forename: Wael M
authors.initials: WM
authors.lastname: El-Sayed
mesh_terms: D016587:Antimutagenic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D000975:Antioxidants / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D001550:Benzamidines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002412:Cations; D004260:DNA Repair / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D009152:Mutagenicity Tests; D013329:Structure-Activity Relationship
chemical_list: D016587:Antimutagenic Agents; D000975:Antioxidants; D001550:Benzamidines; D002412:Cations
keywords: 2′-bichalcophenes; Salmonella typhimurium; antimutagenicity; benzo[a]pyrene; fluoroaryl-2; sodium azide; stille coupling
references.citation: J Toxicol Sci. 2011 Oct;36(5):661-8
references.pmid: 22008541
references.citation: Mutat Res. 1983 Aug;121(2):153-7
references.pmid: 6308440
references.citation: Yakugaku Zasshi. 2000 Dec;120(12):1373-85
references.pmid: 11193386
references.citation: Anal Biochem. 1999 May 1;269(2):337-41
references.pmid: 10222007
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:443-70
references.pmid: 11264465
references.citation: Ann Pharm Fr. 1999 Mar;57(2):108-15
references.pmid: 10365466
references.citation: Mutat Res. 1983 May;113(3-4):173-215
references.pmid: 6341825
references.citation: Drug Des Devel Ther. 2013 Mar 22;7:185-93
references.pmid: 23662048
references.citation: Drug Des Devel Ther. 2013;7:73-81
references.pmid: 23430305
references.citation: Cancer Res. 1982 Nov;42(11):4779-83
references.pmid: 6290047
references.citation: Toxicol Lett. 1992 Oct;63(1):69-74
references.pmid: 1412524
references.citation: J Med Chem. 2003 Oct 23;46(22):4761-9
references.pmid: 14561095
references.citation: Mutat Res. 2000 Feb 16;465(1-2):173-82
references.pmid: 10708984
references.citation: Eur J Nutr. 2012 Apr;51(3):261-79
references.pmid: 22362552
references.citation: Drug Des Devel Ther. 2012;6:279-87
references.pmid: 23091372
references.citation: Acta Trop. 2008 Oct;108(1):6-10
references.pmid: 18722336
references.citation: Biophys Chem. 2007 Mar;126(1-3):140-53
references.pmid: 16831507
references.citation: Bioorg Med Chem. 2011 Jan 15;19(2):978-84
references.pmid: 21194955
references.citation: Jpn J Vet Res. 2005 Feb;52(4):173-84
references.pmid: 15822859
references.citation: Mutat Res. 2011 Sep 1;714(1-2):17-25
references.pmid: 21689667
references.citation: Mutat Res. 1990 Oct;245(2):93-8
references.pmid: 2215556
references.citation: Regul Toxicol Pharmacol. 1998 Oct;28(2):85-95
references.pmid: 9927558
references.citation: J Enzyme Inhib Med Chem. 2004 Apr;19(2):145-55
references.pmid: 15449729
references.citation: Bioorg Med Chem Lett. 2011 Jun 1;21(11):3431-4
references.pmid: 21530247
references.citation: Antimicrob Agents Chemother. 2009 Oct;53(10):4185-92
references.pmid: 19620327